Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational exposure limit variability and hazard characterization alignment-implications for protection from respiratory irritation.

Journal of occupational and environmental hygiene·2026
Same author

A framework for assessing the safety of degraded pharmaceuticals for long-duration space missions - Part 2: framework application in four case studies.

Critical reviews in toxicology·2026
Same author

A framework for assessing the safety of degraded pharmaceuticals for long-duration space missions - Part 1: framework development.

Critical reviews in toxicology·2026
Same author

Analysis of Regulatory Inhalation Unit Risk Estimates for Cobalt: Comparison to Epidemiological Data.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Nitroparaffin transcriptional profiles and toxicokinetics support chemical-specific carcinogenicity assessment.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Many paths to one goal for occupational risk assessment: Insights from a practitioner dialogue.

Journal of occupational and environmental hygiene·2025
Same journal

Effectiveness of Communication Strategies on Risk Perception in Technoscience: A Systematic Literature Review Through an Argumentation Theory Approach.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

The Roles of Place Attachment and Geovisualizations on Hurricane Storm Surge Risk Perceptions and Behavioral Intentions.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Scientists' Experiences With Getting Help Making Strategic Communication Choices.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Correction to "Evolutionarily Optimal Risk Aversion".

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Toward Resilient Cross-Regional Emergency Governance: A Demand-Driven and Propagation-Based Evolutionary Cooperation Framework.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same journal

Competition and Collaboration in the AI Race: Country-LevelDirectional Evidence for Risk Monitoring and Policy.

Risk analysis : an official publication of the Society for Risk Analysis·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

A Bayesian network model for biomarker-based dose response.

C Eric Hack1, Lynne T Haber, Andrew Maier

  • 1Toxicology Excellence for Risk Assessment (TERA), Cincinnati, OH, USA. charles.hack@wpafb.af.mil

Risk Analysis : an Official Publication of the Society for Risk Analysis
|April 24, 2010
PubMed
Summary
This summary is machine-generated.

A novel Bayesian network model integrates diverse data for benzene-induced acute myeloid leukemia (AML) risk assessment. This approach provides a more sensitive benchmark concentration for AML, improving low-dose exposure evaluations.

Related Experiment Videos

Last Updated: Jun 13, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

  • Environmental Health
  • Toxicology
  • Biostatistics

Background:

  • Benzene exposure is a known risk factor for acute myeloid leukemia (AML).
  • Accurate dose-response assessment is crucial for setting safe exposure limits.
  • Traditional methods may not fully capture low-dose effects or integrate complex biomarker data.

Purpose of the Study:

  • To develop and apply a Bayesian network model for exposure-dose-response assessment of benzene-induced AML.
  • To quantitatively link biomarkers of effect to exposure and disease outcomes.
  • To compare the network approach with traditional dose-response analysis methods.

Main Methods:

  • Development of a Bayesian network model integrating diverse data types.
  • Evaluation and comparison of individual biomarkers within the network.
  • Biomarker-based dose-response analysis using the network.
  • Comparative analysis with other dose-response assessment approaches.

Main Results:

  • The Bayesian network model successfully integrated various data for AML risk assessment.
  • The network-derived benchmark concentration for AML was significantly lower (by an order of magnitude) than conventional methods.
  • The model demonstrated the utility of biomarker information in low-dose exposure scenarios.

Conclusions:

  • Bayesian networks offer a robust quantitative approach for linking biomarkers to exposure and disease.
  • This method provides a more sensitive point of departure for AML risk assessment at lower benzene exposures.
  • Integrating precursor dose-response information improves the scientific validity of risk assessments.